tetradecanoylphorbol acetate and pramipexole

tetradecanoylphorbol acetate has been researched along with pramipexole in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borwege, S; Joyce, JN; Millan, MJ; Presgraves, SP	1
Akbartabar Touri, M; Delaviz, H; Ghavamzadeh, M; Jafari Barmak, M; Parishani, M; Sadeghi, H; Zarezade, V	1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and pramipexole

Article	Year
Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells. Experimental neurology, 2004, Volume: 190, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Antibodies; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetradecanoylphorbol Acetate; Thiazoles; Tretinoin	2004
Pramipexole reduces inflammation in the experimental animal models of inflammation. Immunopharmacology and immunotoxicology, 2017, Volume: 39, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Benzothiazoles; Carrageenan; Disease Models, Animal; Inflammation; Male; Mice; Parkinson Disease, Secondary; Pramipexole; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate	2017

Article

Year

Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.

Experimental neurology, 2004, Volume: 190, Issue:1

Topics: 1-Methyl-4-phenylpyridinium; Antibodies; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetradecanoylphorbol Acetate; Thiazoles; Tretinoin

2004

Pramipexole reduces inflammation in the experimental animal models of inflammation.

Immunopharmacology and immunotoxicology, 2017, Volume: 39, Issue:2

Topics: Animals; Anti-Inflammatory Agents; Benzothiazoles; Carrageenan; Disease Models, Animal; Inflammation; Male; Mice; Parkinson Disease, Secondary; Pramipexole; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate

2017